Evolus (EOLS) Gross Margin (2019 - 2026)

Evolus (EOLS) posted Gross Margin of 66.86% for Q1 2026, up 1.82% on a QoQ basis from 65.66% in Q4 2025, and down 123.0% year-over-year from 290.68% in Q1 2025.

Evolus (EOLS) Gross Margin (2019 - 2026) Analysis & Trends

Evolus' Gross Margin history runs 8 years deep, the most recent figure standing at 66.86% for Q1 2026.

  • Quarterly Gross Margin fell 123.0% year-over-year to 66.86% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 66.06% (down 236.0% YoY) and the FY2025 annual result came in at 66.33%, down 214.0% from the prior year.
  • Gross Margin was 66.86% for Q1 2026 at Evolus, up from 65.66% in the prior quarter.
  • Across five years, Gross Margin topped out at 70.89% in Q1 2023 and bottomed at 57.43% in Q2 2022.
  • A 5-year average of 65.98% and a median of 66.67% in 2024 frame the typical range for Gross Margin.
  • Annual changes were most pronounced in 2023 — Gross Margin jumped 1275 bps — and 2025, when it plunged 503 bps.
  • Evolus' Gross Margin stood at 62.6% in 2022, then grew by 2 bps to 63.56% in 2023, then advanced by 5 bps to 66.67% in 2024, then decreased by 2 bps to 65.66% in 2025, then climbed by 2 bps to 66.86% in 2026.
  • Business Quant data shows EOLS's Gross Margin at 66.86% in Q1 2026, 65.66% in Q4 2025, and 66.47% in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Gross Margin (Qtr)
1 Haleon 87.22 Bn 85.35 Bn - -
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn 49.52%
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn 71.66%
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn 62.93%
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn 82.93%
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn - -
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn 32.97%
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn 98.31%
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn 57.26%
10 Evolus 390.47 Mn 340.68 Mn 48.90 Mn 66.86%

Historic Data

Download Data
DateValue
Mar 31, 2026 66.86%
Dec 31, 2025 65.66%
Sep 30, 2025 66.47%
Jun 30, 2025 65.31%
Mar 31, 2025 68.09%
Dec 31, 2024 66.67%
Sep 30, 2024 68.92%
Jun 30, 2024 70.35%
Mar 31, 2024 68.26%
Dec 31, 2023 63.56%
Sep 30, 2023 69.15%
Jun 30, 2023 70.19%
Mar 31, 2023 70.89%
Dec 31, 2022 62.60%
Sep 30, 2022 60.21%
Jun 30, 2022 57.43%
Mar 31, 2022 61.05%
Dec 31, 2021 54.31%
Sep 30, 2021 56.93%
Jun 30, 2021 56.69%